Taguchi, Akira http://orcid.org/0000-0003-2620-1487
Hagino, Hiroshi
Inoue, Daisuke
Endo, Naoto
Society, Japan Osteoporosis
Funding for this research was provided by:
Japan Society for the Promotion of Science (21K09885, 22K10208)
Article History
Received: 20 June 2023
Accepted: 2 July 2023
First Online: 30 July 2023
Declarations
:
: AT has received lecture fees from Asahi Kasei Pharma Corp., Daiichi Sankyo Co. Ltd, Chugai Pharmaceutical Co. Ltd, and Teijin Pharma Ltd. He has received a consultation fee from Media Corp. Ltd. HH received lecture fees or grants outside the submitted work from Amgen Inc., Asahi Kasei Pharma Corp., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Eli Lilly Japan Co. Ltd., Mitsubishi Tanabe Pharma Corp., Mochida Pharma Co. Ltd., Ono Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Pfizer Japan Inc., Taisho Pharmaceutical Co. Ltd., Teijin Pharma Ltd., and UCB Japan Co. Ltd. DI has received lecture fees from Asahi Kasei Pharma Corp., Daiichi Sankyo Co. Ltd, and Teijin Pharma Ltd. NE have no conflicts of interests.
: Our study did not require ethics approval from the Matsumoto Dental University ethics committee because neither individual data nor any kind of intervention was included in the protocol or the results. The respondents in this survey, all of whom represented their respective institutions, provided informed consent. This questionnaire-based survey was conducted according to the ethical guidelines for epidemiological studies from the Japanese Ministry of Health, Labour and Welfare. This study was conducted in accordance with the Declaration of Helsinki and its later amendments or comparable ethical standards.